Best GLP-1 for PCOS: Ranked for Weight Loss, Cycles, and Fertility

Why GLP-1s Work So Well for PCOS

Polycystic ovary syndrome is often described as a reproductive condition, but the driver in most cases is metabolic - and that is precisely why GLP-1 medications address it more directly than most treatments.

The core cycle in PCOS works like this:

• Insulin resistance forces the pancreas to produce more insulin to keep blood glucose in range.
• High circulating insulin stimulates the ovaries to produce more androgens (testosterone and related hormones).
• Elevated androgens disrupt follicle development, which prevents regular ovulation - producing irregular or absent periods, and causing symptoms like hirsutism and acne.
• Weight gain worsens insulin resistance, tightening the loop.

GLP-1 medications intervene at the top of that chain. They improve insulin sensitivity directly and produce substantial weight loss, which lowers circulating insulin, which reduces ovarian androgen production, which allows normal follicle development and ovulation to resume.

What the Research Actually Shows

The evidence base for GLP-1s in PCOS has grown considerably, though it remains smaller than the obesity trial data.

Dedicated research is ongoing. The RESTORE trial is examining injectable semaglutide specifically in women with PCOS, with early findings suggesting it may improve reproductive health beyond its effects on weight loss alone - which would indicate a direct hormonal benefit rather than a purely weight-mediated one.

The Rankings

On pure metabolic effect, tirzepatide is the strongest candidate - it produces the most weight loss and has powerful effects on insulin sensitivity through dual GLP-1 and GIP action, which maps directly onto PCOS pathophysiology.

On practical access, semaglutide through an affordable programme usually wins, because the binding constraint for most women with PCOS is getting any GLP-1 at all rather than choosing between them. A medication you can afford beats a marginally better one you cannot.

GLP-1s and Fertility: What to Know

This has become one of the most discussed effects of GLP-1 medications, sometimes described in the press as an "Ozempic baby boom." The underlying phenomenon is real, and it has two distinct causes.

1. Restored Ovulation

Many women with PCOS are subfertile specifically because they ovulate irregularly or not at all. When weight loss and improved insulin sensitivity restore ovulation, fertility can return - sometimes quickly, and often unexpectedly for women who had assumed they could not conceive easily.

2. Reduced Contraceptive Reliability

This one catches people out. GLP-1 medications slow gastric emptying, which can affect absorption of oral contraceptives. Combined with vomiting or diarrhoea during titration, the reliability of the pill can be reduced.

For women who are trying to conceive, GLP-1s are increasingly used as a pre-conception intervention - improving metabolic health and restoring ovulation before trying, then stopping. Clinicians also report patients responding better to fertility medications after GLP-1 treatment.

Critical: Pregnancy Planning

The practical sequence most clinicians use looks like this:

1. Treat - use the GLP-1 to reduce weight and improve insulin sensitivity, with reliable non-oral contraception in place
2. Stabilise - confirm cycles have regularised and ovulation has returned
3. Discontinue with a prescriber-directed washout period before trying to conceive
4. Maintain - protein intake, resistance training, and sleep to hold the metabolic gains without the medication

That last step matters more than it sounds. Weight regain after stopping is well documented, and regaining weight can undo the ovulation benefit. Our guides on weight regain after stopping and preserving muscle mass are directly relevant.

Why It Is Not Covered, and What to Do

No GLP-1 is FDA-approved for PCOS. Prescribing for PCOS is off-label - entirely legal and common, but it means insurers have no approved indication to point to when deciding coverage.

That creates a frustrating situation many women with PCOS know well: the medication clearly addresses the underlying mechanism of your condition, and your plan will not pay for it.

Routes That Sometimes Work

• Document insulin resistance or prediabetes. If you meet criteria for prediabetes or type 2 diabetes, a diabetes-indicated GLP-1 like Ozempic or Mounjaro may be coverable on that basis.
• Use the obesity indication if you qualify. If your BMI meets the threshold for Wegovy or Zepbound, apply under that indication rather than PCOS.
• Document comorbidities. Hypertension, sleep apnea, dyslipidaemia, and fatty liver all strengthen a prior authorisation.
• Appeal denials. First denials are common and frequently overturned with proper documentation.
• Cash-pay programmes. When coverage genuinely is not available, an all-inclusive compounded programme removes the insurance question entirely.

GLP-1s vs Metformin

Metformin has been the standard metabolic treatment for PCOS for decades. Here is how they compare.

These are not mutually exclusive - some clinicians use them together, and metformin remains a reasonable first step given its cost and coverage. The case for adding or switching to a GLP-1 is strongest when metformin alone has not produced enough weight loss to restore cycles, since the 5% threshold is where reproductive benefits typically begin.

Frequently Asked Questions